Search results for: 'ami infrastructure development access adas'

08 Dec 2023  |  South Asia, Middle East & North Africa  |  Market Research

India s Facility Management Growth Opportunities

Technologies, Business Models, and Service Integration are Focal Points of Facility Management Innovation Culture

Infographics

×

This Frost & Sullivan report analyzes the Indian FM market, covering market drivers, restraints, forecasts, trends, and the competitive landscape of the overall market. It provides end-user vertical analysis for commercial, institutional, public/infrastructure, industrial, and other sectors. It features a 2020-to-2028 timeframe, with 2022 being the...

The study aims to research, analyze, and forecast the automotive market in Uzbekistan according to 3 segments: passenger vehicles, commercial vehicles, and buses and minibuses. Research Scope • Macroeconomic figures and market trends (social, political, economic, and technological trends influencing the automotive market in the country) • Business...

The primary objective of this experiential study is to identify growth opportunities for your company using new technologies such as Artificial Intelligence (AI), Blockchain, and Robotic Process Automation (RPA). A Blockchain is a new data structure that creates trusted, distributed digital ledgers for assets and other data. It is an immutable rec...

Smart sensors employs microelectromechanical systems (MEMS) and very-large-scale integration (VLSI) technology to function effectively. A smart sensor is a device that receives input from the physical world, and upon detection, leverages internal computing power to carry out predefined actions to provide optimized output. Key operations of smart se...

14 Feb 2022  |  Global  |  Market Research

Global Neurovascular Disease Management Growth Opportunities

AI-based Triaging and Simulation Technology to Aid Expansion of Neurointerventional Stroke Management Procedures

Infographics

×

The global prevalence of stroke is estimated to be about 100 million as of 2021. In the past 30 years, improvements in stroke prevention, acute treatment, and neuro-rehabilitation have contributed to a significant reduction in the burden of stroke in high-income countries. Neurovascular solutions companies recognize the importance of optimized solu...

18 Aug 2022  |  Global  |  Technology Research

AR Cloud: The Next Frontier in Augmented Reality

Growth Opportunities in Unifying the Digital and the Physical World for Truly Immersive Experiences

Infographics

×

Advanced technologies such as augmented reality (AR), virtual reality (VR), and extended reality (XR) have seen considerable development in recent years. Many mobile and head-mounted devices support immersive technologies, which require a point cloud for multiple users to view and access information in real time. Companies have invested in building...

15 May 2025  |  Global  |  Market Research

Immunomodulator Therapeutics Market, Global, 2024–2030

Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies

Infographics

×

This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...

The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for m...

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposi...